---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-030432"
form_type: "8-K"
ticker: "ACUT"
cik: "0001850767"
company_name: "Accustem Sciences Inc."
filed_at: "2021-12-03T23:59:59+00:00"
generated_at: "2026-06-28T03:56:25.829186+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Accustem Sciences redomiciled from UK to Delaware via court-approved scheme of arrangement

## Summary
- Redomiciled from UK to Delaware via court-approved scheme of arrangement effective Dec 1, 2021.
- Share exchange: 20 old ordinary shares for 1 new share; 10 ADS for 1 new share; 9,999,132 new shares issued.
- New Accustem authorized 150M common shares ($0.001 par) and 10M preferred; 2021 Plan reserves 2M shares.
- New options for 1,069,244 shares, exercise prices $0.42-$1.06, expiring August/November 2031.
- Adopted new bylaws, indemnification agreements, and code of business conduct.

## SEC filing metadata
- accession: 0001493152-21-030432
- form_type: 8-K
- ticker: ACUT
- cik: 0001850767
- company_name: Accustem Sciences Inc.
- filed_at: 2021-12-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.01, 3.02, 5.02, 5.03, 5.05, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850767/000149315221030432/0001493152-21-030432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850767/000149315221030432/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-030432
- JSON: https://secwatch.observer/filing/0001493152-21-030432.json
- Plain text: https://secwatch.observer/filing/0001493152-21-030432.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.